Insight

Ghassan Abou-Alfa: ERBB2-altered gallbladder cancer characterization in Chile

genosciencepharma.com

Oct 9, 2024, 16:50

Ghassan Abou-Alfa: ERBB2-altered gallbladder cancer characterization in Chile

Ghassan Abou-Alfa, Medical Oncologist, Memorial Sloan Kettering Cancer Center, shared a post on X:

“Congratulations and thank you Sebastian Mondaca on superb valuable effort for Chile. Memorial Sloan Kettering Cancer Center, MSK Department of Medicine, Ghassan Abou-Alfa and team are proud for contributing to ERBB2-altered gallbladder cancer characterization in Chile!”

Clinical and genomic characterization of ERBB2-altered gallbladder cancer

Authors: Sebastian Mondaca, Nikolaus Schultz, Juan Carlos Roa, Henry S. Walch, Santiago Sepulveda, James J. Harding, Amin Yaqubie, Patricia Garcia, Gloria Aguayo, Bruno Nervi, Bob T. Li and Ghassan K. Abou-Alfa.

Amin Yaqubie Bob T. Li Bruno Nervi cancer cancer awareness cancer care fight against cancer Ghassan Abou-Alfa Ghassan K. Abou-Alfa Global fight against cancer Gloria Aguayo Henry S. Walch James J. Harding JCO Journal of Clinical Oncology Juan Carlos Roa Memorial Sloan Kettering Cancer Center MSK Department of Medicine Nikolaus Schultz OncoDaily Oncology Patricia Garcia Santiago Sepulveda Sebastian Mondaca

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage